Get more information on Infection Surveillance Solutions Market - Request Sample Report
The Infection Surveillance Solutions Market Size was assessed at USD 657.20 million in 2023, and is predicted to increase at a CAGR of 13.9% from 2024 to 2031 and to reach USD 1861.61 million by 2031.
Infection surveillance solution monitoring software helps healthcare facilities like hospitals and others report patient data to state and federal authorities. This programme notifies hospital Internet Protocol (IP) addresses in the event of an infection, allowing HAI specialists and nurses to treat infected patients and avoid infection epidemics. These solutions are used to detect infections and assess the effectiveness of preventative actions. They are also required to assist in the diagnosis of antibiotic-resistant organisms and infections caused by non-sanitized medical devices.
Surgical databases, Accurate employee health information, and real-time medical records are among the benefits of these systems for healthcare facilities. Surveillance strategies are employed to control infection patterns. The market's expansion is aided by the enhanced analytics capability of IT systems. Hospitals have emerged as the primary end-user in these sectors due to their high adoption rate for preserving electronic healthcare records and managing real-time pharmacy.
Infection surveillance systems are meant to continuously monitor and analyse health-related data to make sure that preventive actions are properly applied. Hospital-acquired infections, also known as nosocomial infections, are caused by a variety of factors including poor hygienic conditions, neglect, lowered patient immunity, the invasion of drug-resistant bacteria, and procedures that diminish the impact of continuing treatments.
DRIVERS
COVID-19 is becoming more common throughout the world.
Hospital-acquired infections are becoming more prevalent.
Antibiotic stewardship programmes are becoming more widely used.
Surgery is becoming more common.
The ageing population and the prevalence of chronic diseases are on the rise.
Increasing investment in healthcare systems
RESTRAINTS
The cost of deployment for small healthcare organisations is substantial.
Medical practitioners' reluctance to use cutting-edge healthcare IT solutions
OPPORTUNITIES
The healthcare industry is becoming more consolidated.
Software that runs on the cloud
Markets that are still developing
CHALLENGES
There is a scarcity of trained healthcare IT professionals.
Concerns about data security
Coronavirus is a recently recognized novel Covid that causes an irresistible infection.COVID-19, which was mostly unknown until the epidemic in Wuhan, China, in December 2019, has gone from a regional issue to a global epidemic in just a few weeks. On March 11, 2020, the World Health Organization (WHO) proclaimed COVID-19 an outbreak. As of August 24, 2020, Worldometers reported 23.6 million verified COVID-19 cases worldwide. As a result, healthcare facilities are experiencing a severe scarcity of beds, healthcare workers, and essential medical supplies. This is motivating healthcare companies to implement HCIT solutions including infection surveillance, EHRs, telemedicine platforms, and patient registries to track and manage COVID-19 infections in patients and gather data for improved patient care.
By Product & Services
Infection surveillance software solutions and infection surveillance services are two types of infection surveillance solutions available on the market. Infection surveillance software was the largest section of the infection surveillance solutions market in 2023. The increased necessity to prevent HAIs and the expanding number of surgical procedures can both be related to this segment's substantial proportion. On-premise and web-based software make up the infection surveillance software industry. The on-premise software segment of the infection surveillance software market held the highest proportion of the market in 2023. The necessity to preserve access to healthcare IT systems while reducing the danger of data breaches and external threats is largely responsible for this segment's substantial share.
Product support and maintenance services, training and consulting services, and implementation services make up the infection surveillance services industry. The infection surveillance services market was led by the product support and maintenance services segment in 2023. Interoperability and software complexity issues are dealt with by product support and maintenance services. These services ensure that clients (healthcare providers) have access to the vendor's technical knowledge base, receive help from its product support team, and learn how to administer applications. These factors are propelling the product support and maintenance services segment forward.
By End User
Long-term care facilities, Hospitals, and other end users make up the infection surveillance solutions market. Infection surveillance systems accounted for the highest share of the market in 2023, according to hospitals. The enormous patient load, increasing prevalence of HAIs, and increasing incidences of SSIs all contribute to this segment's large share. In addition, the COVID-19 pandemic has encouraged hospital usage of infection surveillance technology.
North America represented the biggest portion of the contamination reconnaissance arrangements market, trailed by Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The huge portion of this locale can be credited to elements, for example, the developing solidification among medical services suppliers, far and wide reception of medical services IT answers for abridge the rising medical services costs, expanding occurrence of HAIs, and the rising number of COVID-19 patients in the US. The presence of an enormous number of players in the locale is likewise a key variable adding to the huge portion of North America in the contamination observation arrangements market.
Need any customization research on Infection Surveillance Solutions Market - Enquiry Now
Some of the major key players are as follows: Atlas Medical Software, RL Solutions, HyGreen, Inc., GOJO Industries, Inc., Becton Dickinson and Company, Truven Health Analytics, Deb Group Ltd., Baxter International Inc, Premier, Inc., and Wolters Kluwer N.V., and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 657.20 Million |
| Market Size by 2031 | US$ 1861.61 Million |
| CAGR | CAGR of 13.9% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product & Services (Software, Services) • By End User (Hospital, Long-Term Care Facilities, Other) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Atlas Medical Software, RL Solutions, HyGreen, Inc., GOJO Industries, Inc., Becton, Dickinson and Company, Truven Health Analytics, Deb Group Ltd., Baxter International Inc, Premier, Inc., and Wolters Kluwer N.V., and other players. |
| DRIVERS | • COVID-19 is becoming more common throughout the world. • Hospital-acquired infections are becoming more prevalent. • Antibiotic stewardship programmes are becoming more widely used. |
| RESTRAINTS | • The cost of deployment for small healthcare organisations is substantial. • Medical practitioners' reluctance to use cutting-edge healthcare IT solutions |
Ans: The Infection Surveillance Solutions Market size was valued at US$ 657.20 Mn in 2023.
Ans: The Infection Surveillance Solutions Market is growing at a CAGR of 13.9% over the forecast period 2024-2031.
Drivers, Restraints, Opportunities, and Challenges are the factors of marketing dynamics Bioinformatics market.
Software, Services are the sub segments of Infection Surveillance Solutions Market.
North America represented the biggest portion of the contamination reconnaissance arrangements market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Infection Surveillance Solutions Market Segmentation, By Product & Services
8.1 Software
8.1.1 Web-Based Software
8.1.2 On-Premise Software
8.2 Services
8.2.1 Product Support & Maintenance
8.2.2 Training & Consulting services
8.2.3 Implementation Services
9. Infection Surveillance Solutions Market Segmentation, By End User
9.1 Hospitals
9.1.1 Large Hospitals
9.1.2 Medium Sized Hospitals
9.1.3 Small Hospitals
9.2 Long-Term Care Facilities
9.2.1 Nursing Homes
9.2.2 Skilled Nursing Facilities
9.2.3Assisted- Living Facilities
9.2 Others
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 USA
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 South Korea
10.4.3 China
10.4.4 India
10.4.5 Australia
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.1 Israel
10.5.2 UAE
10.5.3 South Africa
10.5.4 Rest
10.6 Latin America
10.6.1 Brazil
10.6.2 Argentina
10.6.3 Rest of Latin America
11 Company Profiles
11.1 Atlas Medical Software
11.1.1 Financial
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 RL Solutions
11.3 HyGreen, Inc.
11.4 GOJO Industries, Inc.
11.5Becton, Dickinson and Company
11.6Truven Health Analytics
11.7 Deb Group Ltd.
11.8 Baxter International Inc
11.9 Premier, Inc.
11.10 Wolters Kluwer N.V.
12 Competitive Landscape
12.1 Competitive Benchmark
12.2 Market Share Analysis
12.3 Recent Developments
13 Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Product & Services
Software
Web-Based Software
On-Premise Software
Services
Product Support & Maintenance
Training & Consulting services
Implementation Services
By End User
Hospitals
Large Hospitals
Medium Sized Hospitals
Small Hospitals
Long-Term Care Facilities
Nursing Homes
Skilled Nursing Facilities
Assisted- Living Facilities
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The global medical x-ray market is projected to reach 24.50 billion by 2032 which is anticipated to expand at a CAGR of 6.22% from 2024 to 2032.
The Inflammatory Bowel Disease Drugs Market size was valued at USD 21.15 Billion in 2023 and is expected to reach USD 27.65 Billion By 2031 and grow at a CAGR of 3.47% over the forecast period of 2024-2031.
The Diabetic Neuropathy Market Size was valued at USD 4.36 billion in 2023 and is witnessed to reach USD 8.38 billion by 2032 and grow at a CAGR of 7.81% over the forecast period 2024-2032.
The Low-Pressure Liquid Chromatography Market Size was valued at USD 7.25 billion in 2023 and is expected to reach USD 13.72 billion by 2032 and grow at a CAGR of 7.36% over the forecast period 2024-2032.
The Biodegradable Medical Plastics Market Size was valued at USD 1.7 Bn in 2023 and will reach USD 4.5 Bn by 2032 and grow at a CAGR of 11.5% Over the Forecast Period of 2024-2032.
The Point of Care Lipid Test Market size was estimated USD 305.53 million in 2023 and is expected to reach USD 444.36 million by 2032 at a CAGR of 4.25% during the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
